DHDavid Hughes
David Hughes
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
David Hughes has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Wells
Global Process R&D, AstraZeneca, Leicestershire, U.K.
3 shared publications - Bernard Kaptein
InnoSyn BV Urmonderbaan 22 6167 RD Geleen The Netherlands
3 shared publications Bill Hinkley
GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A.
3 shared publicationsIan Andrews
GlaxoSmithKline, Stevenage, Hertfordshire, U.K.
3 shared publications- John Hayler
Chemical Development, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom
3 shared publications Peter Dunn
Pfizer Global Research and Development, Ramsgate Road, Sandwich, U.K.
3 shared publications
Latest Publications
- 26 January 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (5) , 1272-1287
Highlights of the Recent Patent Literature: Continuous Chemistry in the Pharmaceutical Industry
- 26 January 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (5) , 1272-1287
Highlights of the Recent Patent Literature: Continuous Chemistry in the Pharmaceutical Industry
- 13 July 2022
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (8) , 2224-2239
Highlights of the Recent Patent Literature: Focus on Asymmetric Organocatalysis
- 13 July 2022
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (8) , 2224-2239
Highlights of the Recent Patent Literature: Focus on Asymmetric Organocatalysis
- 27 January 2022
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (7) , 1878-1899
Highlights of the Recent Patent Literature─Focus on Biocatalysis Innovation
- 27 January 2022
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (7) , 1878-1899
Highlights of the Recent Patent Literature─Focus on Biocatalysis Innovation
- 17 September 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (10) , 2192-2204
Review of Synthetic Routes and Crystalline Forms of the Oncology Drugs Capmatinib, Selpercatinib, and Pralsetinib
- 17 September 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (10) , 2192-2204
Review of Synthetic Routes and Crystalline Forms of the Oncology Drugs Capmatinib, Selpercatinib, and Pralsetinib
- 19 April 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (5) , 1089-1111
Quest for a Cure: Potential Small-Molecule Treatments for COVID-19, Part 2
- 19 April 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (5) , 1089-1111
Quest for a Cure: Potential Small-Molecule Treatments for COVID-19, Part 2
- 4 May 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (10) , 1850-1860
Applications of Flow Chemistry in the Pharmaceutical Industry—Highlights of the Recent Patent Literature
- 4 May 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (10) , 1850-1860
Applications of Flow Chemistry in the Pharmaceutical Industry—Highlights of the Recent Patent Literature
- 18 February 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (3) , 347-362
Review of Synthetic Routes and Crystalline Forms of the Antiandrogen Oncology Drugs Enzalutamide, Apalutamide, and Darolutamide
- 18 February 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (3) , 347-362
Review of Synthetic Routes and Crystalline Forms of the Antiandrogen Oncology Drugs Enzalutamide, Apalutamide, and Darolutamide
- 19 September 2019
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 23 (11) , 2302-2322
Patent Review of Synthetic Routes and Crystalline Forms of the CFTR-Modulator Drugs Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor
- 19 September 2019
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 23 (11) , 2302-2322
Patent Review of Synthetic Routes and Crystalline Forms of the CFTR-Modulator Drugs Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor
- 21 June 2019
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 23 (7) , 1298-1307
Review of the Patent Literature: Synthesis and Final Forms of Antiviral Drugs Tecovirimat and Baloxavir Marboxil
- 21 June 2019
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 23 (7) , 1298-1307
Review of the Patent Literature: Synthesis and Final Forms of Antiviral Drugs Tecovirimat and Baloxavir Marboxil